Adaptam Therapeutics is a biotechnology startup focused on discovering and developing new medicines for patients with rare genetic diseases. Their approach leverages cutting-edge protein degradation technologies to target the underlying causes of these conditions. The company aims to bring innovative therapies to market for previously untreatable diseases.